{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:20:40Z","timestamp":1773897640551,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Natriuretic peptides are useful prognostic markers in patients with heart failure and this study aims to evaluate the association between N-terminal pro-brain natriuretic peptide and outcomes in patients with a continuous-flow left ventricular assist device.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Adult patients with a continuous-flow left ventricular assist device as bridge to transplant or destination therapy and discharged from hospital were included in the study. Multi-variable Cox regression models with natriuretic peptide as a time-dependent covariate modelling multiple measures per patient, and cubic spline analysis were used to evaluate the association between natriuretic peptides and patient outcomes, taking median N-terminal pro-brain natriuretic peptide of 244 pmol\/L as the reference value. Heart transplant was considered a competing event for mortality analysis, while death was considered a competing event for transplantation analysis. A multivariable cause-specific Cox regression model evaluated the relationship between natriuretic peptides and heart failure hospitalizations while considering heart failure hospitalizations as recurring events and adjusting for competing risks of death and transplant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This retrospective cohort study included 161 adults. During a median follow-up of 4.7 years, 49 patients died, 79 received a heart transplant and 66 were hospitalized for heart failure. In comparison to the median N-terminal pro-brain natriuretic peptide level, patients exceeding 350 pmol\/L had a 19% increased mortality (HR 1.19, 95%CI 1.01\u20131.15) while patients exceeding 330 pmol\/L had a 16% higher risk of hospitalization (HR 1.16, 95%CI 1.01\u20131.12).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In patients with a continuous-flow left ventricular assist device, serial assessments of natriuretic peptides may help provide personalized patient care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13019-025-03422-w","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T03:07:41Z","timestamp":1744772861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A two-centre study investigating the association between brain natriuretic peptides &amp; outcomes in continuous flow left ventricular assist device recipients"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6187-8461","authenticated-orcid":false,"given":"Maria","family":"Lambadaris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Foroutan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie KK","family":"Vishram-Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Sophie S.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filio","family":"Billia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C","family":"Alba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"issue":"4","key":"3422_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/MAT.0000000000000234","volume":"61","author":"T Sato","year":"2015","unstructured":"Sato T, Seguchi O, Iwashima Y, Yanase M, Nakajima S, Hieda M, et al. Serum brain natriuretic peptide concentration 60 days after surgery as a predictor of Long-Term prognosis in patients implanted with a left ventricular assist device. ASAIO J. 2015;61(4):373\u20138.","journal-title":"ASAIO J"},{"issue":"1","key":"3422_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5507\/bp.2017.003","volume":"161","author":"M Hegarova","year":"2017","unstructured":"Hegarova M, Kubanek M, Netuka I, Maly J, Dorazilova Z, Gazdic T, et al. Clinical correlates of B-type natriuretic peptide monitoring in outpatients with left ventricular assist device. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161(1):68\u201374.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"1","key":"3422_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.21037\/jtd.2018.12.43","volume":"11","author":"M Papathanasiou","year":"2019","unstructured":"Papathanasiou M, Pizanis N, Tsourelis L, Koch A, Kamler M, Rassaf T, et al. Dynamics and prognostic value of B-type natriuretic peptide in left ventricular assist device recipients. J Thorac Dis. 2019;11(1):138\u201344.","journal-title":"J Thorac Dis"},{"issue":"12","key":"3422_CR4","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.cardfail.2022.09.007","volume":"28","author":"J Boulet","year":"2022","unstructured":"Boulet J, Nayak A, Mehra MR. Hemodynamic aberrancies in left ventricular assist Device-Associated heart failure syndromes. J Card Fail. 2022;28(12):1738\u201340.","journal-title":"J Card Fail"},{"issue":"8","key":"3422_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1515\/CCLM.2002.130","volume":"40","author":"S Masson","year":"2002","unstructured":"Masson S, Vago T, Baldi G, Salio M, De Angelis N, Nicolis E, et al. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin Chem Lab Med. 2002;40(8):761\u20133.","journal-title":"Clin Chem Lab Med"},{"issue":"5 Pt 1","key":"3422_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0002-8703(98)70041-9","volume":"135","author":"K Maeda","year":"1998","unstructured":"Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135(5 Pt 1):825\u201332.","journal-title":"Am Heart J"},{"issue":"3","key":"3422_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMoa020233","volume":"347","author":"AS Maisel","year":"2002","unstructured":"Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161\u20137.","journal-title":"N Engl J Med"},{"issue":"2","key":"3422_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0735-1097(01)01744-2","volume":"39","author":"LK Morrison","year":"2002","unstructured":"Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39(2):202\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"3422_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S1053-2498(01)00289-3","volume":"20","author":"H Milting","year":"2001","unstructured":"Milting H, Banayosy EL, Kassner A, Fey A, Sarnowski O, Arusoglu P. The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types. J Heart Lung Transpl. 2001;20(9):949\u201355.","journal-title":"J Heart Lung Transpl"},{"issue":"7","key":"3422_CR10","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/S0735-1097(01)01677-1","volume":"38","author":"R Sodian","year":"2001","unstructured":"Sodian R, Loebe M, Schmitt C, Potapov EV, Siniawski H, M\u00fcller J, et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol. 2001;38(7):1942\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3422_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.healun.2005.08.001","volume":"25","author":"S Xydas","year":"2006","unstructured":"Xydas S, Rosen RS, Ng C, Mercando M, Cohen J, DiTullio M, et al. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transpl. 2006;25(1):7\u201315.","journal-title":"J Heart Lung Transpl"},{"key":"3422_CR12","doi-asserted-by":"crossref","unstructured":"Wehbe RM, Jensen BC, Chang PP, Bowen A, Sheridan BC, Katz JN. Abstract 57: NT-proBNP Decreases Exponentially Following Left Ventricular Assist Device Implantation and Can Predict Future Hospitalization. Circulation: Cardiovascular Quality and Outcomes. 2013;6(suppl_1):A57-A.","DOI":"10.1161\/circoutcomes.6.suppl_1.A57"},{"issue":"4","key":"3422_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/MAT.0000000000001524","volume":"68","author":"A Ali","year":"2022","unstructured":"Ali A, Akintoye E, Ruiz Duque E, Kshetri R, Shetty S, Sharma UC, et al. Prognostic implications of ambulatory N-Terminal Pro-B-Type natriuretic peptide changes in patients with Continuous-Flow left ventricular assist devices. ASAIO J. 2022;68(4):524\u201330.","journal-title":"ASAIO J"},{"issue":"2","key":"3422_CR14","doi-asserted-by":"publisher","first-page":"e005094","DOI":"10.1161\/CIRCHEARTFAILURE.118.005094","volume":"12","author":"T Imamura","year":"2019","unstructured":"Imamura T, Jeevanandam V, Kim G, Raikhelkar J, Sarswat N, Kalantari S, et al. Optimal hemodynamics during left ventricular assist device support are associated with reduced readmission rates. Circ Heart Fail. 2019;12(2):e005094.","journal-title":"Circ Heart Fail"},{"issue":"3","key":"3422_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MAT.0000000000000483","volume":"63","author":"LE Couperus","year":"2017","unstructured":"Couperus LE, Delgado V, Khidir MJH, Vester MPM, Palmen M, Fiocco M, et al. Pump speed optimization in stable patients with a left ventricular assist device. ASAIO J. 2017;63(3):266\u201372.","journal-title":"ASAIO J"},{"issue":"5","key":"3422_CR16","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/j.cardfail.2022.03.140","volume":"28","author":"A Hajduczok","year":"2022","unstructured":"Hajduczok A, Maucione C, Julian K, Bent B, DiChiacchio L, Ali O, et al. Hemodynamic optimization of left ventricular assist devices during right heart catheterization ramp studies. J Card Fail. 2022;28(5):S53\u20134.","journal-title":"J Card Fail"},{"key":"3422_CR17","doi-asserted-by":"publisher","first-page":"170420","DOI":"10.1016\/j.peptides.2020.170420","volume":"135","author":"MSS Knudsen","year":"2021","unstructured":"Knudsen MSS, Eismark F, Goetze JP, Gustafsson F, Wolsk E. The contribution of cardiac and extracardiac factors to NT-proBNP concentrations in patients with advanced heart failure before and after left ventricular assist device implantation. Peptides. 2021;135:170420.","journal-title":"Peptides"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03422-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-025-03422-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03422-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T03:07:41Z","timestamp":1744772861000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-025-03422-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3422"],"URL":"https:\/\/doi.org\/10.1186\/s13019-025-03422-w","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the research ethics board at each institution (17-6078\u2013 January 2018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}